The treatment of hypertension has become the most important intervention in the management of all forms of chronic kidney disease. Chronic Kidney Disease and Hypertension is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease. In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devices. Written by expert authors, Chronic Kidney Disease and Hypertension provides an up-to-date perspective on management and treatment and how it may re-shape practice approaches tomorrow. …mehr
The treatment of hypertension has become the most important intervention in the management of all forms of chronic kidney disease. Chronic Kidney Disease and Hypertension is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease. In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devices.
Written by expert authors, Chronic Kidney Disease and Hypertension provides an up-to-date perspective on management and treatment and how it may re-shape practice approaches tomorrow.
Matthew R. Weir, MD Professor and Director, Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA Edgar V. Lerma, MD Clinical Professor of Medicine, Section of Nephrology, Christ Medical Center, University of Illinois at Chicago/Advocate, Oak Lawn, IL, USA
Inhaltsangabe
Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future.- Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD.- Resistant hypertension in patients with chronic kidney disease.- Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease.- Novel Molecules.- Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?.- Renal Sympathetic Denervation.- Novel baroreceptor activation therapy.- Blood Pressure Vaccines.- Masked Hypertension: Does it Lead to CVD or CKD?.- White Coat Hypertension- Do We Really Understand It Now?.- Uric Acid And Hypertension - Is There Really A Link?.- Preeclampsia: Angiogenic factors, blood pressure, and the kidney.- Inflammation and Hypertension.- Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations.- Endocrine Hypertension and Chronic Kidney Disease.- Hypertension in Children with Chronic Kidney Disease.- Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link.
Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future.- Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD.- Resistant hypertension in patients with chronic kidney disease.- Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease.- Novel Molecules.- Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?.- Renal Sympathetic Denervation.- Novel baroreceptor activation therapy.- Blood Pressure Vaccines.- Masked Hypertension: Does it Lead to CVD or CKD?.- White Coat Hypertension- Do We Really Understand It Now?.- Uric Acid And Hypertension - Is There Really A Link?.- Preeclampsia: Angiogenic factors, blood pressure, and the kidney.- Inflammation and Hypertension.- Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations.- Endocrine Hypertension and Chronic Kidney Disease.- Hypertension in Children with Chronic Kidney Disease.- Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link.
Rezensionen
"This book reviews the etiology, pathogenesis, and treatment guidelines for patients with chronic kidney disease and hypertension. The goal is to provide a guide for all healthcare professionals, both clinical and research, in the management of hypertension, especially in the expanding population of patients with chronic kidney disease and end-stage renal disease. ... This is an excellent resource for all practitioners, educators, and students on the intricacies of hypertension and how it affects all patients." (Temitope Shodunke, Doody's Book Reviews, October, 2015)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497